{"id":"rufinamid","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Headache","drugRate":"27%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"19%","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"16%","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"12%","severity":"common","organSystem":""},{"effect":"Somnolence","drugRate":"11%","severity":"common","organSystem":""},{"effect":"Diplopia","drugRate":"9%","severity":"common","organSystem":""},{"effect":"Tremor","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Nystagmus","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Blurred Vision","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Ataxia","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Upper Abdominal Pain","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Anxiety","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Constipation","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Back Pain","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Gait Disturbance","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Vertigo","drugRate":"3%","severity":"common","organSystem":""}],"contraindications":["Breastfeeding (mother)","Depressive disorder","Disease of liver","Hepatic failure","Leukopenia","Renal dialysis","Shortened QT interval","Suicidal thoughts"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"da9ee326-a383-4d46-9d4e-fcc2be3d2680","title":"RUFINAMIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]"},"ecosystem":[],"mechanism":{"target":"Carbonic anhydrase 5A, mitochondrial, Sodium channel alpha subunit"},"_scrapedAt":"2026-03-28T02:49:12.470Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Lennox-Gastaut syndrome","diseaseId":"lennox-gastaut-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01212458","phase":"","title":"Effect of Oral Rufinamide and Oxcarbazepine on Nerve Excitability, Hyperalgesia, Allodynia and Flare Reaction Compared to Placebo. A Monocenter, Randomized, Double-blind, Cross-over Study","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2010-10","conditions":"Healthy Subjects","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Rufinamid","genericName":"Rufinamid","companyName":"University of Zurich","companyId":"university-of-zurich","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}